Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 62332-768

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 62332-768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Paroxetine 25)

This text appears to be detailing information about a medication called Paroxetine Extended Release Tablets, USP. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The details include the manufacturer, packaging specifics, and a GTIN code. Additionally, it mentions that the product should only be dispensed at the request of a physician and that the packaging should not be altered.*

FDA Label Image

30 Tablets (Paroxetine 37 5)

FDA Label Image

Paroxetine-fig1.jpg (Paroxetine Fig1)

This text appears to provide information on drug interactions involving various medications such as Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin. The table includes data related to parameters like Cmax and AUC, as well as fold change and 90% confidence intervals. This data may be used to evaluate the impact of drug interactions on the pharmacokinetics of the mentioned medications.*

FDA Label Image

Paroxetine-fig2.jpg (Paroxetine Fig2)

This appears to be a comparison of the pharmacokinetics (PK) parameters of various drugs with a reference drug. The table shows the fold change and 90% confidence interval for Cmax (maximum concentration in blood) and AUC (area under the concentration-time curve) for different drugs like Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam, which are administered at different doses and frequencies. This information may be used to understand how the drug levels in the body change relative to a reference drug.*

FDA Label Image

Paroxetine-fig3.jpg (Paroxetine Fig3)

This text includes information about population description based on renal impairment (mild, moderate, severe), hepatic impairment, age (>65 years), gender (males), PK fold change and 90% CI related to various aspects of drug pharmacokinetics (Cmax, AUC, Cmin), as well as changes relative to a reference group. This data may be used for dosing adjustments and understanding pharmacokinetic changes in different populations.*

FDA Label Image

Paroxetine-str.jpg (Paroxetine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.